# A Phase 1 Study of XH-S003 in Healthy Volunteers

> **NCT05946876** · PHASE1 · COMPLETED · sponsor: **S-INFINITY Pharmaceuticals Co., Ltd** · enrollment: 77 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** XH-S003 (A)
- **OTHER:** Placebo (B)

## Key facts

- **NCT ID:** NCT05946876
- **Lead sponsor:** S-INFINITY Pharmaceuticals Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-24
- **Primary completion:** 2024-07-11
- **Final completion:** 2024-08-14
- **Target enrollment:** 77 (ACTUAL)
- **Last updated:** 2024-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946876, "A Phase 1 Study of XH-S003 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05946876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*